Table 4. The adjusted risks for rapid decline in renal function and change of eGFR according to Angiopoietin-2 quartile.
Angiopoietin-2a | Rapid decline in renal function | Change of eGFR | ||
Odds ratio (95% Cl) | P-value | Unstandardized coefficient βb (95% Cl) | P-value | |
Quartile 1 | Reference | Reference | ||
Quartile 2 | 3.40(1.32–8.75) | 0.01 | −1.03(−2.63,0.57) | 0.1 |
Quartile 3 | 3.04(1.18–7.82) | 0.02 | −1.66(−3.25,−0.07) | 0.03 |
Quartile 4 | 2.96(1.13–7.76) | 0.02 | −1.73(−3.33,−0.11) | 0.03 |
Abbreviations: CI, Confidence Interval; eGFR, estimated glomerular filtration rate.
Adjusted model: age, sex, cardiovascular disease, diabetes mellitus, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers use, estimated glomerular filtration rate, hemoglobin, serum calcium and cholesterol levels, log serum albumin and phosphate, , and urine protein-creatinine ratio cut at 1 g/g.
Angiopoietin-2 quartile cut at 1494.1, 1948.8, and 2593.1 pg/ml.
β expressed as ml/min/1.73 m2/year in eGFR.